Together, these results indicate that the inhibitory effect of exogenous irisin on the FNDC5-PGC1α-PPARγ pathway causes a decrease in PL expression and secretion under AP induction, an underlying mechanism for the development and aggregation of AP. The gene discussed is PPARG; the disease is alkaline phosphatase measurement.